Anti-E Cadherin antibody [EPR16845-108]
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Recombinant Monoclonal E Cadherin antibody. Suitable for IP, WB and reacts with Mouse, Rat samples. Cited in 6 publications.
View Alternative Names
CD324, Cadherin-1, ARC-1, Epithelial cadherin, Uvomorulin, E-cadherin, Cdh1
- WB
Supplier Data
Western blot - Anti-E Cadherin antibody [EPR16845-108] (AB181296)
Exposure time : Lanes 1-2 : 30 seconds; Lanes 3-4 : 15 seconds.
Blocking/Dilution buffer : 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID : 11076937; PMID : 11953314).
All lanes:
Western blot - Anti-E Cadherin antibody [EPR16845-108] (ab181296) at 1/1000 dilution
Lane 1:
Rat spleen lysate at 10 µg
Lane 2:
Mouse plasma at 10 µg
Lane 3:
Mouse serum at 10 µg
Lane 4:
Mouse brain lysate at 10 µg
Secondary
Lanes 1 and 4:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Lanes 2 - 3:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 97 kDa
Observed band size: 120 kDa,84 kDa
true
- WB
Supplier Data
Western blot - Anti-E Cadherin antibody [EPR16845-108] (AB181296)
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 28220208).
Low expression : spleen, skeletal muscle (PMID : 7734012).
The identity of the bands at 37 kDa and 60 kDa are unknown.
Samples are non-boiled as boiling may cause protein aggregation.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-E Cadherin antibody [EPR16845-108] (ab181296) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-ABCB4 antibody [EPR28774-92] (<a href='/en-us/products/primary-antibodies/abcb4-antibody-epr28774-92-ab317573'>ab317573</a>) at 1/1000 dilution
Lane 1:
Mouse liver tissue lysate non-membrane fraction at 20 µg with NFDM/TBST
Lane 2:
Mouse liver tissue lysate membrane fraction at 20 µg with NFDM/TBST
Lane 3:
Mouse liver tissue lysate at 20 µg with NFDM/TBST
Lane 4:
Mouse spleen tissue lysate at 20 µg with NFDM/TBST
Lane 5:
Mouse skeletal muscle tissue lysate at 20 µg with NFDM/TBST
Lane 6:
Rat liver tissue lysate at 20 µg with NFDM/TBST
Lane 7:
Rat spleen tissue lysate at 20 µg with NFDM/TBST
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 140-150 kDa,36 kDa,125 kDa
true
Exposure time: 180s
- IP
Supplier Data
Immunoprecipitation - Anti-E Cadherin antibody [EPR16845-108] (AB181296)
E Cadherin was immunoprecipitated from 1 mg of mouse serum with ab181296 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab181296 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : Mouse serum 10 μg (Input).
Lane 2 : ab181296 IP in mouse serum.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab181296 in mouse serum.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 1 second.
All lanes:
Immunoprecipitation - Anti-E Cadherin antibody [EPR16845-108] (ab181296)
Predicted band size: 97 kDa
false
- WB
Supplier Data
Western blot - Anti-E Cadherin antibody [EPR16845-108] (AB181296)
Lane 1:
Western blot - Anti-E Cadherin antibody [EPR16845-108] (ab181296) at 1/20000 dilution
Lane 2:
Western blot - Anti-E Cadherin antibody [EPR16845-108] (ab181296) at 1/100000 dilution
All lanes:
His-tagged mouse E-Cadherin active protein (aa1-709) at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 32 kDa,97 kDa
Observed band size: 120 kDa,84 kDa
true
Exposure time: 10s
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
E-Cadherin participates in establishing and maintaining adherens junctions which are vital for tissue structure. E-Cadherin operates as a core component of the cadherin-catenin complex which links the protein to the actin cytoskeleton. Through this linkage E-Cadherin plays an important role in signaling pathways that influence cellular growth and differentiation. The protein's ability to mediate intercellular connections also regulates cellular motility and supports basic aspects of cell behavior in epithelial tissues.
Pathways
E-Cadherin influences both the Wnt signaling pathway and the epithelial-to-mesenchymal transition (EMT). Within the Wnt signaling pathway E-Cadherin partners with β-catenin a significant player in transcription regulation and cell signaling. Disruption in E-Cadherin's adhesive functionality can lead to increased β-catenin availability affecting downstream transcriptional control. In the EMT process E-Cadherin loss characterizes an important step in which cells gain migratory and invasive properties typically seen during metastasis in cancer progression.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Journal of cellular and molecular medicine 27:456-469 PubMed36651490
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 22:221 PubMed35773697
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 13:778479 PubMed35309056
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 25: PubMed34841435
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:1102 PubMed34504556
2021
Applications
Unspecified application
Species
Unspecified reactive species
Gut microbes 12:1788891 PubMed32686598
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com